SHE:300436 Revenue

In the year 2025, Fujian Cosunter Pharmaceutical had annual revenue of 416.37M CNY, down -5.68%. Fujian Cosunter Pharmaceutical had revenue of 100.54M in the quarter ending December 31, 2025, a decrease of -12.69%.

Revenue

416.37M

Revenue Growth

-5.68%

P/S Ratio

44.68

Revenue / Employee

547.86K

Employees

760

Market Cap

18.60B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	416.37M	-25.08M	-5.68%
Dec 31, 2024	441.46M	18.74M	4.43%
Dec 31, 2023	422.71M	36.95M	9.58%
Dec 31, 2022	385.77M	15.32M	4.14%
Jan 1, 2022	370.44M	1.95M	0.53%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Wanbangde Pharmaceutical Holding Group	1.14B
Shandong Buchang Pharmaceuticals	10.96B
China Resources Double-Crane Pharmaceutical	10.73B
ApicHope Pharmaceutical Group	940.78M
Wedge Industrial	1.32B
Tonghua Dongbao Pharmaceutical	2.95B
Joincare Pharmaceutical Group Industry	14.85B
Hybio Pharmaceutical	898.10M

Revenue Rankings